CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients

作者
Fabian Birzele,Edgar Voß,Adam Nopora,Konrad Honold,Florian Heil,Sabine Lohmann,Henk M.W. Verheul,Christophe Le Tourneau,Jean‐Pierre Delord,Carla van Herpen,Devalingam Mahalingam,Andrew L. Coveler,Valérie Méresse,Stefan Weigand,Valeria Runza,Michael A. Cannarile
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:21 (12): 2753-2762 被引量:56
标识
DOI:10.1158/1078-0432.ccr-14-2141
摘要

PURPOSE: CD44, a cell surface glycoprotein, plays important roles in the development, progression, and metastasis of various tumor types. The aim of this study was to investigate how the expression of CD44 isoforms influences the interaction with hyaluronic acid (HA) and how differential isoform expression impacts antitumoral responses in vivo to treatment with RG7356, a humanized anti-CD44 antibody inhibiting CD44-HA interaction. EXPERIMENTAL DESIGN: CD44 isoform expression on various tumor cell lines was analyzed by RNASeq while data on patients with different tumor types were obtained from the publicly available TCGA RNASeq dataset as well as a phase I clinical study (NCT01358903). We analyzed the link between HA production and CD44 isoform expression as well as the consequences of blocking the CD44-mediated cell adhesion to HA using RG7356. The correlation between CD44 isoform expression and antitumor response to RG7356 treatment was investigated in the corresponding murine xenograft in vivo models as well as in a subset of patients treated with RG7356 from a recently completed phase I clinical trial. RESULTS: CD44 isoform expression, in particular expression of CD44s, is associated with HA production and predicts response to treatment with RG7356 in tumor xenograft models. Furthermore, patient data suggest that CD44 isoform status is a potential predictive biomarker for clinical response to treatment with RG7356. CONCLUSIONS: We provide new insights into the close interplay between CD44 and HA and a potential biomarker to enrich patient responses to RG7356 in the clinic.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zyy发布了新的文献求助10
刚刚
刚刚
zan12131发布了新的文献求助30
刚刚
义气傲薇发布了新的文献求助10
1秒前
2秒前
2秒前
helping完成签到 ,获得积分10
2秒前
苏邑发布了新的文献求助10
2秒前
长风赴宴完成签到 ,获得积分10
2秒前
2秒前
2秒前
甜蜜发带完成签到 ,获得积分0
2秒前
3秒前
11完成签到,获得积分10
3秒前
酷炫师发布了新的文献求助10
3秒前
3秒前
Lucas的应助被Humingyu采纳,获得10
3秒前
5秒前
5秒前
Nia发布了新的文献求助10
5秒前
简单山水发布了新的文献求助10
5秒前
小孙大王发布了新的文献求助10
6秒前
6秒前
6秒前
踏实初蓝完成签到,获得积分20
6秒前
科研岗完成签到,获得积分10
6秒前
7秒前
唐唐发布了新的文献求助10
7秒前
xhy完成签到 ,获得积分10
7秒前
ini发布了新的文献求助10
7秒前
yan完成签到,获得积分10
7秒前
风_Feng完成签到,获得积分10
8秒前
流沙发布了新的文献求助10
8秒前
我是老大的应助被Rufus采纳,获得10
8秒前
8秒前
贝奇发布了新的文献求助10
9秒前
天真梦槐完成签到,获得积分10
9秒前
10秒前
理想三寻发布了新的文献求助10
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181379
求助须知:如何正确求助?哪些是违规求助? 9571317
关于积分的说明 21817457
捐赠科研通 7777820
什么是DOI,文献DOI怎么找? 3433454
关于科研通互助平台的介绍 2557692
邀请新用户注册赠送积分活动 2479523